ResMed Inc.

ResMed Inc.

RMDยทNYSE

$186.46

+2.0%
HealthcareMedical - Devices

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

At a Glance

Live Snapshot
Market Cap$27.05B
EPS9.5500
P/E Ratio19.52
Earnings Date07/30/2026
3Y+44.0%
5Y+74.0%
10Y+180.0%
3Y+80.0%
5Y+125.0%
10Y+297.0%
3Y+399.0%
5Y+118.0%
10Y+220.0%
ResMed Inc.

ResMed Inc. Profit Bridge

RMD ยท NYSE
Revenue5.15B
Cost of Goods Sold (2.09B)
Gross Profit3.05B
Operating Expenses (1.37B)
Operating Income1.69B
Interest Expense (12.61M)
Other Income/Expense-7.80M
Pretax Income1.68B
Income Tax (276.84M)
Net Income1.40B
Net Income
1.40B

Profitability Analysis

Gross Margin

59.4%

Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.

Operating Margin

32.7%

Outstanding operational efficiency. The company generates substantial profit from core operations.

Net Profit Margin

27.2%

Exceptional profitability. The company converts a significant portion of revenue to bottom-line earnings.

Effective Tax Rate

16.5%

Moderate tax rate typical for most corporations. Represents standard tax burden on profits.

Profitability Insight

Exceptional profitability across all levels: Strong pricing power, efficient operations, and healthy bottom line indicate a high-quality business with sustainable competitive advantages.

ResMed Inc. Income Statement

RMD โ€ข NYSE

ResMed Inc. Income StatementJun 2025Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017Jun 2016Jun 2015Jun 2014Jun 2013Jun 2012Jun 2011Jun 2010Jun 2009Jun 2008Jun 2007Jun 2006
REVENUE
5.1B
4.7B
4.2B
3.6B
3.2B
3B
2.6B
2.3B
2.1B
1.8B
1.7B
1.6B
1.5B
1.4B
1.2B
1.1B
920.7M
835.4M
716.3M
607M
GROSS PROFIT
(2.1B)
(2B)
(1.9B)
(1.6B)
(1.4B)
(1.2B)
(1.1B)
(978M)
(865M)
(772.2M)
(667.5M)
(565.2M)
(573.8M)
(547.8M)
(501.8M)
(436.9M)
(366.9M)
(341.6M)
(331.8M)
(230.1M)
3.1B
2.7B
2.4B
2B
1.8B
1.7B
1.5B
1.4B
1.2B
1.1B
1B
989.8M
940.7M
820.7M
741.3M
655.5M
553.8M
493.8M
384.5M
376.9M
OPERATING INCOME
(1.4B)
(1.3B)
(1.2B)
(1B)
(935.4M)
(908.7M)
(957.3M)
(820.3M)
(775.9M)
(637.5M)
(602.2M)
(584.7M)
(585.8M)
(525.3M)
(473.4M)
(412.1M)
(363.5M)
(348.4M)
(294.3M)
(244.5M)
(991M)
(917.1M)
(874M)
(739.4M)
(670.4M)
(676.7M)
(645M)
(600.4M)
(554M)
(488.1M)
(472.6M)
(450.4M)
(430.8M)
(401.6M)
(371.2M)
(328.9M)
(289.9M)
(278.1M)
(237.3M)
(200.2M)
(331.3M)
(307.5M)
(287.6M)
(253.6M)
(225.3M)
(201.9M)
(180.7M)
(155.1M)
(144.5M)
(118.7M)
(114.9M)
(118.2M)
(120.1M)
(109.7M)
(92M)
(75.2M)
(63.1M)
(60.5M)
(50.1M)
(37.2M)
1.7B
1.3B
1.1B
1B
903.7M
809.7M
579.3M
541.8M
425.8M
429M
409.2M
405.1M
354.8M
294.4M
266.9M
240.4M
190.3M
143M
90.2M
131.3M
PRE-TAX INCOME
(12.6M)
(45.7M)
(47.4M)
(22.3M)
(24M)
(40.4M)
(36.2M)
(28.4M)
(28.2M)
(11.2M)
(5.8M)
(6.1M)
(6.4M)
(4.8M)
(1.8M)
(10.1M)
(10.1M)
(10.1M)
(1.3M)
(1.3M)
-12.6M
-45.7M
-47.4M
-22.3M
-23.6M
-39.4M
-33.9M
-12M
-11.2M
5.7M
20.4M
25.1M
32.5M
29.1M
26M
14M
10.2M
0.0
0.0
0.0
(47.3M)
(110.7M)
(62.1M)
(31.1M)
(39.8M)
(30.1M)
(131.7M)
(64.8M)
(77.5M)
(30.8M)
(14.7M)
(16.1M)
(34.9M)
(14M)
(10.1M)
(8M)
(10.6M)
(9.8M)
(6.9M)
(7.1M)
-7.8M
-55.1M
-30.2M
-39.8M
-20M
-76.6M
-60.4M
-20.5M
-7.1M
10.6M
26.7M
26M
30.3M
37.5M
36.8M
20.2M
11.4M
14.9M
7.8M
2.1M
1.7B
1.3B
1.1B
960.5M
883.7M
733.1M
518.8M
521.3M
418.7M
439.6M
435.9M
431.1M
385.1M
331.9M
303.7M
260.6M
201.7M
157.9M
98M
133.4M
NET INCOME
(276.8M)
(243.8M)
(204.1M)
(181M)
(409.2M)
(111.4M)
(114.3M)
(205.7M)
(76.5M)
(87.2M)
(83M)
(85.8M)
(78M)
(77.1M)
(76.7M)
(70.5M)
(55.2M)
(47.6M)
(31.7M)
(45.2M)
1.4B
1B
897.6M
779.4M
474.5M
621.7M
404.6M
315.6M
342.3M
352.4M
352.9M
345.3M
307.1M
254.9M
227M
190.1M
146.4M
110.3M
66.3M
88.2M

SEC Filings

RMD - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
10-Q

10-Q 2026 Q1

Q1

May 01, 2026
March 31, 2026
2026
8-K

8-K 2026

N/A

April 30, 2026
April 24, 2026
2026
8-K

8-K 2026

N/A

April 30, 2026
April 30, 2026
2026
10-Q

10-Q 2025 Q4

Q4

January 30, 2026
December 31, 2025
2025
8-K

8-K 2026

N/A

January 29, 2026
January 29, 2026
2026
8-K

8-K 2025

N/A

November 20, 2025
November 19, 2025
2025
10-Q

10-Q 2025 Q3

Q3

October 31, 2025
September 30, 2025
2025
8-K

8-K 2025

N/A

October 30, 2025
October 30, 2025
2025
DEF 14A

DEF 14A 2025

N/A

October 02, 2025
June 30, 2025
2025
8-K

8-K 2025

N/A

August 18, 2025
August 15, 2025
2025
Showing 1 to 10 of 361 filings